Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07637578 |
| Title | A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma (CORE-MM) |
| Acronym | CORE-MM |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | SCRI Development Innovations, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Colorado Blood Cancer Institute | RECRUITING | Denver | Colorado | 80218 | United States | Details |
| Rocky Mountain Cancer Center | RECRUITING | Denver | Colorado | 80218 | United States | Details |
| Maryland Oncology Hematology | RECRUITING | Columbia | Maryland | 21044 | United States | Details |
| Willamette Valley Cancer Institute and Research Center | RECRUITING | Eugene | Oregon | 97401 | United States | Details |
| SCRI Oncology Partners | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |